Silverback Therapeutics

-$0.03 (-0.33%) Today
-$0.02 (-0.22%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SBTX and other ETFs, options, and stocks.

About SBTX

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases.

CEO
Laura K. Shawver
Employees
54
Headquarters
Seattle, Washington
Founded
2016

SBTX Key Statistics

Market Cap
315.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
471.95K
High Today
$9.54
Low Today
$8.79
Open Price
$9.21
Volume
699.52K
52 Week High
$63.41
52 Week Low
$8.79

SBTX Earnings

-$1.37
-$0.91
-$0.46
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure